Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,397 | -204,627 | -168,035 | -112,243 | -53,236 |
| Depreciation Amortization | 857 | 2,401 | 1,535 | 684 | 310 |
| Accounts receivable | -6,647 | -3,354 | 4,399 | 10,029 | 12,313 |
| Accounts payable and accrued liabilities | 12,956 | 3,131 | 9,012 | 16,071 | 4,189 |
| Other Working Capital | -11,498 | -11,979 | -5,704 | 2,953 | 2,759 |
| Other Operating Activity | 4,004 | 41,001 | 15,099 | -8,299 | -8,962 |
| Operating Cash Flow | $5,069 | $-173,427 | $-143,694 | $-90,805 | $-42,627 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -43,588 | 107,874 | 20,702 | 109,311 | 54,254 |
| PPE Investments | -48 | -354 | -265 | -253 | -72 |
| Purchase Sale Intangibles | N/A | -8,000 | -8,000 | N/A | N/A |
| Other Investing Activity | 0 | -8,000 | -8,000 | 0 | 0 |
| Investing Cash Flow | $-43,636 | $99,520 | $12,437 | $109,058 | $54,182 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 60,102 | 48,901 | 48,901 | N/A |
| Debt Repayment | N/A | -11,899 | -700 | -700 | -534 |
| Common Stock Issued | 908 | 11,421 | 2,935 | 2,377 | 1,082 |
| Other Financing Activity | -864 | 142,911 | 143,336 | 143,393 | 0 |
| Financing Cash Flow | $44 | $202,535 | $194,472 | $193,971 | $548 |
| Exchange Rate Effect | -172 | -265 | -41 | 23 | 151 |
| Beginning Cash Position | 164,086 | 35,723 | 35,723 | 35,723 | 35,723 |
| End Cash Position | 125,391 | 164,086 | 98,897 | 247,970 | 47,977 |
| Net Cash Flow | $-38,695 | $128,363 | $63,174 | $212,247 | $12,254 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,069 | -173,427 | -143,694 | -90,805 | -42,627 |
| Capital Expenditure | -48 | -354 | -265 | -253 | -72 |
| Free Cash Flow | 5,021 | -173,781 | -143,959 | -91,058 | -42,699 |